Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by narmacon Dec 31, 2022 9:19am
96 Views
Post# 35198269

RE:RE:RE:Midatech at $1.0475

RE:RE:RE:Midatech at $1.0475Hummm,,,,can anyone name a junior company which has issued over 1 Billion shares into the public markets that has actually made it in business down the road in reality??.......I can't think of one!!!,,,,maybe there are,,,,maybe!!,,,,,none of the companies I have followed or been invested in ever did,,,,,,they all failed and imploded,,,,,only the management personel involved made anything!!!

So,,,  here we are decades later and important water passing under our bridge, going from 80 Million shares to 1.17 billion shares and losing every bit of control and direction in the mean time. NOT looking good for sure. 7% ownership and less coming to us initially. The greedy wont be happy until we are <3%,,,,,between the reverse splits coming and the general dilution over the next few years, we will be an unknown within,,,,and that is if this new management team can stay abreast of the science and if any of the science actually works to the point of accreditation by any drug administration on the globe!!


<< Previous
Bullboard Posts
Next >>